|Bid||0.5050 x 1582700|
|Ask||0.5200 x 3535900|
|Day's range||0.5000 - 0.5200|
|52-week range||0.4700 - 0.8076|
|Beta (5Y monthly)||0.35|
|PE ratio (TTM)||N/A|
|Earnings date||23 Feb 2022 - 28 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
While it may not be enough for some shareholders, we think it is good to see the Cynata Therapeutics Limited ( ASX:CYP...
Cynata Therapeutics Limited (ASX: "CYP" or "Cynata"), a clinical-stage biotechnology company specialising in cell therapeutics, has today announced that it has entered into a new strategic partnership agreement ("SPA") with Fujifilm Corporation ("Fujifilm").
We can readily understand why investors are attracted to unprofitable companies. For example, although...